Development of Chitosan/Cyclodextrin Nanospheres for Levofloxacin Ocular Delivery
Development of Chitosan/Cyclodextrin Nanospheres for Levofloxacin Ocular Delivery
About this item
Full title
Author / Creator
Publisher
Basel: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel: MDPI AG
Subjects
More information
Scope and Contents
Contents
Levofloxacin (LVF) is an antibacterial drug approved for the treatment of ocular infections. However, due to the low ocular bioavailability, high doses are needed, causing bacterial resistance. Polymeric nanospheres (NPs) loading antibiotic drugs represent the most promising approach to eradicate ocular infections and to treat pathogen resistance....
Alternative Titles
Full title
Development of Chitosan/Cyclodextrin Nanospheres for Levofloxacin Ocular Delivery
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_12c3135b135249c995bfddb31e7d012b
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_12c3135b135249c995bfddb31e7d012b
Other Identifiers
ISSN
1999-4923
E-ISSN
1999-4923
DOI
10.3390/pharmaceutics13081293
